Yüklüyor......

Minimal Residual Disease in Acute Myeloid Leukemia

Technological advances in the laboratory have lead to substantial improvements in clinical decision-making by the use of pre-treatment prognostic risk stratification factors in acute myeloid leukemia (AML). Unfortunately similar progress has not been made in treatment response criteria, with the def...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Hourigan, Christopher S., Karp, Judith E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2013
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4163748/
https://ncbi.nlm.nih.gov/pubmed/23799371
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2013.100
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!